IHS Chemical Week

EnviroTech :: R&D

Bayer HealthCare and Drug Development Company Covance Enter Strategic Partnership

5:40 AM MDT | May 30, 2012 | Natasha Alperowicz

Bayer HealthCare and Covance (Princeton, NJ) will establish a long-term strategic partnership in the area of clinical drug development, including R&D services related to phase II-IV clinical studies and central laboratory services. The new partnership marks the next step in cooperation both partners have developed over the past few years and represents the efforts to maximize its benefits across the Bayer HealthCare organization, Bayer says. Bayer’s goal is to leverage Covance’s broad range of experience and services across the R&D portfolio...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa